Richter S, Seah J-A, Pond GR, Gan HK, Mackenzie MJ, Hotte SJ, Mukherjee SD, Murray N, Kollmannsberger C, Heng D, Haider MA, Halford R, Ivy SP, Moore MJ, Sridhar SS. Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib. CUAJ [Internet]. 2014 Dec. 15 [cited 2024 May 6];8(11-12):398-402. Available from: https://cuaj.ca/index.php/journal/article/view/2426